Author

Anna Whaite

Observed names: A. Whaite, Whaite A

Observed institutions: Guy's Hospital, Mayo Clinic, Churchill Hospital, National Hospital for Neurology and Neurosurgery, Liverpool Womens NHS Foundation Trust

ORCID: 0000-0003-4485-0341

Observed ORCID: 0000-0003-4485-0341

OpenAlex ID: A5002877976

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

2017 · Davina J Hensman Moss, Antonio F Pardiñas, et al. · The Lancet Neurology · 311

Breast and Prostate Cancer Risks for MaleBRCA1andBRCA2Pathogenic Variant Carriers Using Polygenic Risk Scores

2021 · Daniel R Barnes, Valentina Silvestri, et al. · JNCI Journal of the National Cancer Institute · 45

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

2011 · David G. Cox, Jacques Simard, et al. · Human Molecular Genetics · 44

Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study

2018 · Paul McNulty, Richard Pilcher, et al. · Journal of Huntington s Disease · 35

Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice

2024 · Olga Tsoulaki, Marc Tischkowitz, et al. · British Journal of Cancer · 24

Meaningful and Measurable Health Domains in Huntington’s Disease: Large-Scale Validation of the Huntington’s Disease Health-Related Quality of Life Questionnaire Across Severity Stages

2019 · Aileen K. Ho, Mike C. Horton, et al. · Value in Health · 9

Quantifying evidence for phenotypic specificity (PP4) for syndromic phenotypes: Large-scale integration of rare germline FH variants from diagnostic laboratory testing for HLRCC and renal cancer

2025 · Sophie Allen, Charlie F. Rowlands, et al. · Genetics in Medicine · 3

Works count: 9

Citation count: 471

H-index: 6

I10-index: 5